Close

GSK and Vir Biotechnology Announce EMA Review of Dual-Action Monoclonal Antibody VIR-7831 for the Early Treatment of COVID-19

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 5/16/2024

1. SPY
2. WMT
3. CSCO
4. GAMI
5. AMC
6. CB
7. DOW
8. DT
9. UAA
10. GME


Go back to GSK and Vir Biotechnology Announce EMA Review of Dual-Action Monoclonal Antibody VIR-7831 for the Early Treatment of COVID-19
(NASDAQ: VIR) Delayed: 9.93 -0.09 (0.9%)
Previous Close $10.02    52 Week High $ 
Open $9.99    52 Week Low $ 
Day High $10.09    P/E N/A 
Day Low $9.84    EPS $ 
Volume 420,988